Genetic Literacy ProjectCAR T-Cell Therapy Shows Potential to Fight HIVR & D MagazineResearchers have turned to gene therapy in an effort to destroy HIV infected cells in the body, and also create long-term immunity from the disease over the long haul… Continue reading
Genetic Literacy ProjectCAR T-Cell Therapy Shows Potential to Fight HIVR & D MagazineResearchers have turned to gene therapy in an effort to destroy HIV infected cells in the body, and also create long-term immunity from the disease over the long haul… Continue reading
GeekWireGene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trialsGeekWireSean Ainsworth joins Immusoft as its new CEO. (Immusoft Photo). Immusoft is looking to get its gene therapy technology into clinical trials, and … Continue reading
Madison.com |
Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What’s behind this eye-popping surge? Taking … Here’s What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release) Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release) The Ledger Gazette –Nasdaq –Post Analyst all 72 news articles » |
Madison.com |
Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What’s behind this eye-popping surge? Taking … Here’s What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release) Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release) The Ledger Gazette –Nasdaq –Post Analyst all 72 news articles » |
Myeloma Research News |
Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice
Myeloma Research News CAR–T cell therapies are based on the genetic manipulation of a patient’s own T-cells. This reprogramming is designed to make the T-cells specific to certain cancer proteins, making them more efficient at eliminating tumors. For multiple myeloma … |
CNBC |
Caltech breakthrough: Bacteria engineered with ‘sonar’ can track, fight disease
CNBC New treatments like immunotherapy and probiotics can send microbe-sized fighters deep inside the body to fight illness and inflammation that has been linked to disease, but there’s a problem — they are being sent into places we can’t see … |
Nasdaq |
Why CRISPR Therapeutics AG Stock Is Rising Today
Motley Fool Specifically, the company announced a underwritten public offering of 5,000,000 of its common shares at a public offering price of $22.75 per share before the start of today’s session. Under normal circumstances, a secondary offering that equates to a … CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release) Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) StockThe Ledger Gazette CRISPR Therapeutics Announces Proposed Public Offering of Common SharesNasdaq CNA Finance (press release) –Post Analyst –Simply Wall St all 69 news articles » |